[Pharmacoeconomics and cost of cancer drugs]. / Farmacoeconomía y los costes de los medicamentos contra el cáncer.
Farm Hosp
; 34 Suppl 1: 12-5, 2010 Mar.
Article
en Es
| MEDLINE
| ID: mdl-20920852
Cancer is a disease of high incidence, which determines that the health systems will be forced to allocation a significant amount of resources. In an era of evidence-based medicine and increasing cost pressures, it is important to understand the relative clinical and economic impact of the many drug treatment strategies available for cancer patients. Currently, resources that may be spent in pharmacoeconomics expenditure are limited so it is necessary to rationalize their consumption and priorize in the allocation of these resources to the options with higher economic advantages. Pharmacoeconomic studies will permit us to know what is the efficiency of different therapeutic alternatives so they will help to determine the therapeutic options that we should use in routine medical practice.
Buscar en Google
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Costos de los Medicamentos
/
Economía Farmacéutica
/
Neoplasias
/
Antineoplásicos
Tipo de estudio:
Health_economic_evaluation
Límite:
Humans
País/Región como asunto:
Europa
Idioma:
Es
Revista:
Farm Hosp
Asunto de la revista:
FARMACIA
/
HOSPITAIS
Año:
2010
Tipo del documento:
Article
Pais de publicación:
España